Correction to “ HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression”EriksenDO, KrogL, OstenfeldEB, et al. HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. Acta Obstet Gynecol Scand. 2026;105(2):377–385. doi:10.1111/aogs.70128.

Documenti analoghi

• HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression
  di: Dina O. Eriksen, et al.
  Pubblicazione: (2026)
• HPV vaccination coverage rate in women undergoing conization for cervical intraepithelial neoplasia in Spain: The  COVAR study
  di: Aureli Torné Blade, et al.
  Pubblicazione: (2025)
• Genotype, cervical intraepithelial neoplasia, and type‐specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women
  di: Mingyang Chen, et al.
  Pubblicazione: (2024)
• Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register‐based study
  di: Dina Overgaard Eriksen, et al.
  Pubblicazione: (2024)
• Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection
  di: Gustavo Hernández-Suárez
  Pubblicazione: (2010)